XML 61 R54.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Business Segment Information - Summary of EBIDTA by Reporting Segment (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Segment Reporting Information [Line Items]        
Adjusted EBITDA $ 27,867 $ 21,123 $ 46,265 $ 36,148
Corporate operating expenses 11,234 11,204 21,967 23,025
Interest expense, net 4,943 1,266 9,501 2,555
Depreciation and amortization 14,032 13,327 28,894 25,997
Share-based compensation expense 9,959 13,246 18,759 26,266
Foreign exchange impact 851 (269) 2,439 (852)
SeaSpine merger-related costs 5,897 8,206 10,376 28,946
Strategic investments 311 309 431 970
Acquisition-related fair value adjustments 6,117 8,149 10,334 19,785
Interest and loss on investments 1,813   1,553  
Litigation and investigation costs (277) 1,291 1,983 1,760
Succession charges 5,346 262 7,556 262
Medical device regulation   2,050   5,679
Loss before income taxes (32,359) (37,918) (67,528) (98,245)
Operating Segments [Member] | Global Spine [Member]        
Segment Reporting Information [Line Items]        
Adjusted EBITDA 27,688 21,258 47,578 36,239
Operating Segments [Member] | Global Orthopedics [Member]        
Segment Reporting Information [Line Items]        
Adjusted EBITDA $ 179 $ (135) $ (1,313) $ (91)